Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Ischemic Heart Disease

Free Subscription 16.03.2026 1 AJR Am J Roentgenol 15 Am Heart J 26 Am J Cardiol 2 Am J Emerg Med 4 Am J Med 8 Angiology 1 Ann Thorac Surg 2 Arterioscler Thromb Vasc Biol 1 Atherosclerosis 4 Can J Cardiol 24 Catheter Cardiovasc Interv 3 Chest 2 Circ Arrhythm Electrophysiol 1 Circ Cardiovasc Imaging 3 Circ Cardiovasc Interv 1 Circ J 3 Circ Res 10 Circulation 2 Clin Cardiol 1 Clin Chem 2 Eur Heart J 2 Heart 1 Hypertension 18 Int J Cardiol 17 J Am Coll Cardiol 2 J Cardiovasc Pharmacol 1 J Clin Endocrinol Metab 6 J Electrocardiol 3 J Mol Cell Cardiol 2 J Nucl Med 2 J Thorac Cardiovasc Surg 1 J Thromb Haemost 3 JAMA 4 Lancet 3 Mayo Clin Proc 6 N Engl J Med 5 PLoS One 1 Prog Cardiovasc Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. NAGAYAMA Y, Emoto T, Hayashi H, Kidoh M, et al
   Coronary Stent Evaluation by CTA: Image Quality Comparison Between Super-Resolution Deep Learning Reconstruction and Other Reconstruction Algorithms.
   AJR Am J Roentgenol. 2023;221:599-610.
   PubMed         Abstract available
   
   

   
   Am Heart J

2. IGLESIAS JF, Roffi M, Heg D, Muller O, et al
   IMPACT OF TOTAL STENT LENGTH ON LONG-TERM OUTCOMES WITH DIFFERENT NEWER-GENERATION DRUG-ELUTING STENT DESIGNS IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: A SUBGROUP ANALYSIS FROM THE BIOSTEMI ES RANDOMIZED TRIAL.
   Am Heart J. 2026 Mar 9:107421. doi: 10.1016/j.ahj.2026.107421.
   PubMed         Abstract available
   
   
3. HEUTS S, Pustjens TFS, Lux A, Gabrio A, et al
   Probabilities of treatment effects in complete or culprit-only revascularization for NSTEMI: a Bayesian re-analysis of the SLIM trial.
   Am Heart J. 2026 Feb 5:107369. doi: 10.1016/j.ahj.2026.107369.
   PubMed         Abstract available
   
   
4. CORTESE B, Mohammed AA, Malakouti S, Sivalingam J, et al
   Antiplatelet treatment after drug-coated balloon treatment: Review of the current evidence and future perspectives.
   Am Heart J. 2026;296:107361.
   PubMed         Abstract available
   
   
5. LIAO W, Rashid M, Brookes CL, Barber S, et al
   Study design for an emulated trial of a 2 arm, parallel, stratified, adaptive, RCT of CABG versus PCI in people requiring myocardial revascularization at high risk (High-Risk REVASC).
   Am Heart J. 2026;296:107368.
   PubMed         Abstract available
   
   
6. DELMAS C, Laine M, Schurtz G, Roubille F, et al
   Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shock.
   Am Heart J. 2023;265:203-212.
   PubMed         Abstract available
   
   
7. DING Y, Li Q, Chen Q, Tang Y, et al
   Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China.
   Am Heart J. 2023;265:180-190.
   PubMed         Abstract available
   
   
8. PARK S, Rha SW, Choi BG, Kim W, et al
   Efficacy and Safety of Cilostazol-Based Triple Antiplatelet Therapy Compared with Clopidogrel-Based Dual Antiplatelet Therapy in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Multicenter, Rando
   Am Heart J. 2023 Jul 3:S0002-8703(23)00172-2. doi: 10.1016/j.ahj.2023.
   PubMed         Abstract available
   
   
9. LI C, Eikelboom JW, Zhong Z, Zhang X, et al
   Efficacy and safety of a bolus of half-dose r-SAK prior to primary PCI in ST-elevation myocardial infarction: Rationale and design of the OPTIMA-6 trial.
   Am Heart J. 2023 Jun 25:S0002-8703(23)00168-0. doi: 10.1016/j.ahj.2023.
   PubMed         Abstract available
   
   
10. WENG Z, Zhao C, Qin Y, Liu C, et al
    Peripheral atherosclerosis in acute coronary syndrome patients with plaque rupture vs plaque erosion: A prospective coronary optical coherence tomography and peripheral ultrasound study.
    Am Heart J. 2023;263:159-168.
    PubMed         Abstract available
    
    
11. ATALLAH J, Chiha T, Chen C, Siller-Matula JM, et al
    Clinical outcomes associated with type II myocardial infarction caused by bleeding.
    Am Heart J. 2023;263:85-92.
    PubMed         Abstract available
    
    
12. SHAH NP, Peterson ED, Page C, Blanco R, et al
    Generalizability of an EHR-Network Dataset to the United States for Cardiovascular Disease Conditions: Comparison of Cerner Real World Data with the National Inpatient Sample.
    Am Heart J. 2023 May 15:S0002-8703(23)00120-5. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available
    
    
13. ANANTH CV, Rutherford C, Rosenfeld EB, Brandt JS, et al
    Epidemiologic trends and risk factors associated with the decline in mortality from coronary heart disease in the United States, 1990-2019.
    Am Heart J. 2023;263:46-55.
    PubMed         Abstract available
    
    
14. BIANCHINI E, Alsubai SE, Alqahtani F, Sgreva S, et al
    Characterization of Biomarker Profiles in Patients with Coronary Artery Disease: A Prospective Coronary Computed Tomography Angiography Study.
    Am Heart J. 2026 Mar 7:107423. doi: 10.1016/j.ahj.2026.107423.
    PubMed         Abstract available
    
    
15. SIMKEVICH M, Chen YY, Parent M, Patel Y, et al
    Systemic inflammation, myocardial fibrosis, and subclinical cardiovascular disease in people living with HIV.
    Am Heart J. 2026 Mar 4:107399. doi: 10.1016/j.ahj.2026.107399.
    PubMed         Abstract available
    
    
16. DURSTENFELD MS, Levkova-Clark M, Ms DL, Schaffer V, et al
    Rationale, design, and baseline characteristics of the Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection: EPIC-HIV Randomized Clinical Trial.
    Am Heart J. 2026 Feb 28:107400. doi: 10.1016/j.ahj.2026.107400.
    PubMed         Abstract available
    
    

    
    Am J Cardiol

17. HARMOUCH W, Thakker R, Shah S, Attaran R, et al
    Optimal Timing of Complete Revascularization in Patients with ST-Elevation Myocardial Infarction and Multivessel Disease: A Systematic Review and Meta-Analysis.
    Am J Cardiol. 2026 Mar 9:S0002-9149(26)00150.
    PubMed         Abstract available
    
    
18. KERNISS H, Hanses U, Ruhle S, Fach A, et al
    Socioeconomic Status and Long-Term Outcomes After ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2026 Feb 27:S0002-9149(26)00094.
    PubMed         Abstract available
    
    
19. OKUTSU M, Fujimoto D, Yuki H, Lee H, et al
    Serial Assessment of Vascular Healing Process After Directional Coronary Atherectomy Followed by Drug-Coated Balloon: An Optical Coherence Tomography Study.
    Am J Cardiol. 2026;264:64-71.
    PubMed         Abstract available
    
    
20. KUMAR S, Giri AR, Nair RM, Kassis N, et al
    Impact of Comprehensive STEMI Protocol on Process Metrics and Clinical Outcomes in STEMI Patients With Nonsystem Delays.
    Am J Cardiol. 2026;264:38-44.
    PubMed         Abstract available
    
    
21. BOURCIER T, Riou J, Khalil WA, Benard T, et al
    Selective Use of Thromboaspiration in STEMI: CMR Evidence Against Routine Practice.
    Am J Cardiol. 2026;263:8-13.
    PubMed         Abstract available
    
    
22. GUNER A, Uzun F, Demirci G, Gokce K, et al
    Cardiovascular Outcomes After Mini-Crush or Double Kissing Crush Stenting Techniques for Complex Bifurcation Lesions: The EVOLUTE-CRUSH Registry.
    Am J Cardiol. 2023;206:238-246.
    PubMed         Abstract available
    
    
23. PARADIES V, Maurina M, Tonino P, Hofma SH, et al
    Comparison of Supraflex Cruz 60 mum Versus Ultimaster Tansei 80 mum Stent Struts in High Bleeding Risk PCI Patients: Study design and Rational of Compare 60/80 HBR trial.
    Am J Cardiol. 2023;206:230-237.
    PubMed         Abstract available
    
    
24. FENG B, Sun Y, Liu L, Sun Y, et al
    Transcutaneous Electrical Acupuncture Point Stimulation Is Cardioprotective for Patients With Stable Ischemic Heart Disease.
    Am J Cardiol. 2023;206:202-209.
    PubMed         Abstract available
    
    
25. COMANICI M, Bhudia SK, Marczin N, Raja SG, et al
    Antiplatelet Resistance in Patients Who Underwent Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis.
    Am J Cardiol. 2023;206:191-199.
    PubMed         Abstract available
    
    
26. MOSLEH W, Mather JF, Delago AJ Jr, Eastman L, et al
    The Benefit of Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Replacement: A Multicenter Retrospective Outcome-Based Study.
    Am J Cardiol. 2023;206:175-184.
    PubMed         Abstract available
    
    
27. CHERBI M, Gerbaud E, Lamblin N, Bonnefoy E, et al
    Cardiogenic Shock in Idiopathic Dilated Cardiomyopathy Patients: Red Flag for Myocardial Decline.
    Am J Cardiol. 2023;206:89-97.
    PubMed         Abstract available
    
    
28. KESTI H, Makinen H, Mattila K, Jaakkola S, et al
    High Bleeding Incidence in Unselected Hospitalized Suspected Non-ST-Segment Elevation Myocardial Infarction Patients Aged Under 65 Years.
    Am J Cardiol. 2023;206:101-104.
    PubMed         Abstract available
    
    
29. VERDOIA M, Zilio F, Gioscia R, Viola O, et al
    Prognostic Impact of Drug-Coated Balloons in Patients With Diabetes Mellitus: A Propensity-Matched Study.
    Am J Cardiol. 2023;206:73-78.
    PubMed         Abstract available
    
    
30. AURIGEMMA C, Massussi M, Fraccaro C, Adamo M, et al
    Impact of Chronic Coronary Artery Disease and Revascularization Strategy in Patients with Severe Aortic Stenosis Who Underwent Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2023;206:14-22.
    PubMed         Abstract available
    
    
31. SURUAGY-MOTTA RFO, da Silva LD, Aguiar AB, da Silva ED, et al
    Outcomes in Patients with Acute Coronary Syndromes and Cancer Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Am J Cardiol. 2026 Mar 6:S0002-9149(26)00106.
    PubMed         Abstract available
    
    
32. NDREPEPA G
    Same-Day Discharge After Percutaneous Coronary Intervention for Chronic Total Occlusions: Patient's Characteristics and Procedural Success Predict Timing of Hospital Leave and Outcome.
    Am J Cardiol. 2026 Mar 4:S0002-9149(26)00126.
    PubMed        
    
    
33. OPOLSKI MP, Dobrolinska MM, Porouchani S, Sobieszek G, et al
    Drug-coated Balloon Only Percutaneous Coronary Intervention For De-novo Chronic Total Occlusion: Insights From The Multicentre International CTO-DENOVO Registry.
    Am J Cardiol. 2026 Mar 4:S0002-9149(26)00127.
    PubMed         Abstract available
    
    
34. SAYAIDEH MA, Honganur NS, Odigwe C, Ruiz B, et al
    Native Coronary Artery Versus Saphenous Vein Graft Percutaneous Coronary Intervention After Coronary Artery Bypass Grafting: A Contemporary Synthesis.
    Am J Cardiol. 2026 Mar 1:S0002-9149(26)00090.
    PubMed         Abstract available
    
    
35. SHIN ES, Kim YH, Kang DO, Kim S, et al
    Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment in Patients with Chronic Kidney Disease.
    Am J Cardiol. 2026 Mar 1:S0002-9149(26)00115.
    PubMed         Abstract available
    
    
36. CHEN J
    "Pregnancy Outcomes in Women with Cardiovascular Disease: A Retrospective Cohort Study from Kaiser Permanente Northern California".
    Am J Cardiol. 2026 Feb 28:S0002-9149(26)00112.
    PubMed        
    
    
37. CHATURVEDI A, Creechan PJ, Hill AP, Lupu L, et al
    Impact of Cangrelor on Outcomes After Percutaneous Coronary Intervention for Acute Coronary Syndrome in High Bleeding Risk Patients.
    Am J Cardiol. 2026 Feb 27:S0002-9149(26)00082.
    PubMed         Abstract available
    
    
38. FAHOURY AM, Kamel-Abusalha L, Didier AJ, Wunderly K, et al
    Association of GLP-1 Receptor Agonist and SGLT2 Inhibitor with Cardiovascular Outcomes after Transcatheter Aortic Valve Replacement.
    Am J Cardiol. 2026 Feb 27:S0002-9149(26)00087.
    PubMed         Abstract available
    
    
39. VICERE A, Carrick D
    A Breath Away from Disaster: Successful Management of Coronary Stent Loss During Complex PCI.
    Am J Cardiol. 2026 Feb 27:S0002-9149(26)00103.
    PubMed         Abstract available
    
    
40. LEONE PP, Mangieri A, Calamita G, Regazzoli D, et al
    DYNAMX Bioadaptor Implantation for Treatment of Complex Coronary Artery Disease - The DYNAMITE Study.
    Am J Cardiol. 2026 Feb 27:S0002-9149(26)00101.
    PubMed         Abstract available
    
    
41. ADAMOPOULOU E, Dimitriadis K, Sakalidis A, Kyriakoulis K, et al
    Association of Coronary Microvascular Dysfunction with Lipoprotein (a) levels in Patients with Non-Obstructive Coronary Artery Disease.
    Am J Cardiol. 2026 Feb 26:S0002-9149(26)00092.
    PubMed         Abstract available
    
    
42. KYRIAKOULIS I, Kumar SS, Palaiodimos L, Kokkinidis DG, et al
    Noninvasive Imaging Modalities for the Evaluation of Coronary Artery Disease Among Patients With High Body Mass Index: A Focus on Coronary Computed Tomography Angiography (CCTA).
    Am J Cardiol. 2026 Feb 19:S0002-9149(26)00066.
    PubMed         Abstract available
    
    

    
    Am J Emerg Med

43. SERT ET, Gul M, Kokulu K, Mutlu H, et al
    Usefulness of the four-variable formula on serial electrocardiograms in detecting subtle anterior myocardial infarction.
    Am J Emerg Med. 2023;73:83-87.
    PubMed         Abstract available
    
    
44. MCLAREN JTT, El-Baba M, Sivashanmugathas V, Meyers HP, et al
    Missing occlusions: Quality gaps for ED patients with occlusion MI.
    Am J Emerg Med. 2023;73:47-54.
    PubMed         Abstract available
    
    

    
    Am J Med

45. SCHADE DS, Hickey M, Eaton RP
    Interpreting the Coronary Artery Calcium Score - Critical Information for the Practicing Physician.
    Am J Med. 2023;136:1070-1075.
    PubMed         Abstract available
    
    
46. FAUCHIER L, Lenormand T, Lochon L, Bisson A, et al
    Reassessing the Association Between Celiac Disease and Cardiovascular Events: A Large Propensity-Matched Analysis from a Global Federated Research Network.
    Am J Med. 2026 Mar 9:S0002-9343(26)00147-6. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available
    
    
47. SCHADE DS, Adolphe A, Blankenship J, Eaton RP, et al
    Ten Reasons to Treat All Individuals with a Positive Coronary Artery Calcium Score.
    Am J Med. 2026 Mar 9:S0002-9343(26)00150-6. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available
    
    
48. AL-OBAIDI A, Pradhan M, Swarup S, Salem D, et al
    Socioeconomic Disadvantage and Cardiovascular Outcomes in Patients with Established Heart Disease: A Systematic Review.
    Am J Med. 2026 Mar 8:S0002-9343(26)00148-8. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available
    
    

    
    Angiology

49. KUCUKUKUR M, Binici R
    Prognostic Value of FIB-4 Index and Non-Alcoholic Fatty Liver Disease in Myocardial Infarction With Non-Obstructive Coronary Arteries: A Prospective Cohort Study.
    Angiology. 2026 Mar 12:33197261427829. doi: 10.1177/00033197261427829.
    PubMed         Abstract available
    
    
50. TABATABAI S, Bazargani N, Osman H, Alhashmi JM, et al
    Differences in Clinical Characteristics and In-Hospital Outcomes of Acute Myocardial Infarction Among Emiratis and Expatriates: Data from the Gulf Region.
    Angiology. 2026 Mar 11:33197261428499. doi: 10.1177/00033197261428499.
    PubMed         Abstract available
    
    
51. YI J, Chai F, Li S, Li Z, et al
    miR-1306-5p Alleviates Myocardial Cell Injury After Acute Myocardial Infarction Via Modulating TET3.
    Angiology. 2026 Mar 11:33197261422807. doi: 10.1177/00033197261422807.
    PubMed         Abstract available
    
    
52. DAOULAH A, Abdul R, Elmahrouk A, Almahmeed W, et al
    Effect of Invasive Hemodynamic Monitoring on the Outcomes of Cardiogenic Shock in Patients With Acute Myocardial Infarction.
    Angiology. 2026 Mar 2:33197251382436. doi: 10.1177/00033197251382436.
    PubMed         Abstract available
    
    
53. MAHMEED WA, Kindi MA, Al-Sarraf A, Amin H, et al
    Residual Cardiovascular Risk Associated with Non-HDL-C in Statin-Treated Patients: Data from the Gulf Triglyceride and Residual Cardiovascular Risk (Gulf CALLS) Cohort.
    Angiology. 2026 Mar 11:33197261422789. doi: 10.1177/00033197261422789.
    PubMed         Abstract available
    
    
54. ANG SP, Chia JE, Krittanawong C, Gregory B, et al
    Trends, Characteristics, and Outcomes of Percutaneous Coronary Intervention Among Kidney Transplant Recipients.
    Angiology. 2026 Mar 10:33197261425811. doi: 10.1177/00033197261425811.
    PubMed         Abstract available
    
    
55. SANAKA H, Cheng CI, Haroun E, Agrawal A, et al
    Contemporary Trends, In-Hospital Outcomes, and Adverse Prognosticators of Sickle Cell Patients with Cardiovascular and Thromboembolic Complications: A National Database Analysis.
    Angiology. 2026 Feb 24:33197261418309. doi: 10.1177/00033197261418309.
    PubMed         Abstract available
    
    
56. SERIN E, Sahin S, Gurdal A, Sarilar M, et al
    Response to Letter Re: "Prognostic Value of the Naples Score in Older Patients With Acute Coronary Syndrome".
    Angiology. 2026 Feb 20:33197261425814. doi: 10.1177/00033197261425814.
    PubMed        
    
    

    
    Ann Thorac Surg

57. DAVID TE
    Cardiovascular Events in Patients with Marfan Syndrome.
    Ann Thorac Surg. 2026 Mar 6:S0003-4975(26)00201.
    PubMed        
    
    

    
    Arterioscler Thromb Vasc Biol

58. KIM S, Park J, Chen HY, Setiawan CH, et al
    Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency.
    Arterioscler Thromb Vasc Biol. 2026 Mar 5. doi: 10.1161/ATVBAHA.125.323399.
    PubMed         Abstract available
    
    
59. WELDY CS, Li JB, Quertermous T
    Adenosine-to-Inosine (A-to-I) RNA Editing by ADAR1 to Control RNA Sensing in Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2026 Feb 26:10.1161/ATVBAHA.125.323847.
    PubMed         Abstract available
    
    

    
    Atherosclerosis

60. AHMED AI, Saad JM, Alahdab F, Han Y, et al
    Prognostic value of positron emission tomography derived myocardial flow reserve: A systematic review and meta-analysis.
    Atherosclerosis. 2023;382:117280.
    PubMed         Abstract available
    
    

    
    Can J Cardiol

61. GUO J, Zhang P
    Do Beta-Blockers Still Benefit Patients After Myocardial Infarction Without Heart Failure?
    Can J Cardiol. 2026 Mar 6:S0828-282X(26)00244-8. doi: 10.1016/j.cjca.2026.
    PubMed        
    
    
62. ZEITOUNI M, Montalescot G, Roule V, Guedeney P, et al
    Definition and prediction of periprocedural myocardial infarction in elective percutaneous coronary intervention: the ALPHEUS-MI study.
    Can J Cardiol. 2026 Feb 26:S0828-282X(26)00140.
    PubMed         Abstract available
    
    
63. KAWTHARANY H, Rayyan A, Mestarihi A, Hamarsha Q, et al
    Beta-Blockers in Patients with Myocardial Infarction and No Heart Failure: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Can J Cardiol. 2026 Feb 26:S0828-282X(26)00157.
    PubMed         Abstract available
    
    
64. PELES I, Barrett O, Cafri C, Garcia-Garcia H, et al
    Predictors of Adverse Outcome in High-Risk Percutaneous Coronary Interventions Patients.
    Can J Cardiol. 2023;39:1369-1379.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

65. KUMAR S, Roomi SS, Muuse J, Wong A, et al
    Protamine Use During Chronic Total Occlusion Percutaneous Coronary Intervention: A Multicenter Registry.
    Catheter Cardiovasc Interv. 2026 Jan 11. doi: 10.1002/ccd.70472.
    PubMed         Abstract available
    
    
66. LIBERMAN F, Padilla LT, Ordonez S, Spaletra PM, et al
    Feasibility and Safety of Same-Day Discharge Following Complex PCI: Sub-Analysis From a Dedicated Same-Day Discharge Radial Lounge Program.
    Catheter Cardiovasc Interv. 2026;107:1206-1210.
    PubMed         Abstract available
    
    
67. NG P, Azzalini L
    Retrograde Balloon-Assisted Subintimal Entry for Chronic Total Occlusion Percutaneous Coronary Intervention.
    Catheter Cardiovasc Interv. 2026 Jan 8. doi: 10.1002/ccd.70467.
    PubMed         Abstract available
    
    
68. SAEED O, Saeed A, Barakat O, Bawjeh A, et al
    Indobufen Dual Antiplatelet Therapy (DAPT) Versus Aspirin Dual Antiplatelet Therapy (DAPT) After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2026 Jan 7. doi: 10.1002/ccd.70463.
    PubMed         Abstract available
    
    
69. KHIALANI B, Sim E, Touma G, Fairley S, et al
    Coronary Slow Flow and No-Reflow During Percutaneous Coronary Intervention: Contemporary Insights Into Imaging-Guided Prediction, Prevention, and Management.
    Catheter Cardiovasc Interv. 2026 Jan 7. doi: 10.1002/ccd.70468.
    PubMed         Abstract available
    
    
70. KANEKO U, Kashima Y, Fujita T, Carlino M, et al
    Synergistic Application of HydroDynamic contrast Recanalization and IVUS-Guided Tip Detection-Antegrade Dissection and Re-Entry in CTO PCI.
    Catheter Cardiovasc Interv. 2026;107:1173-1177.
    PubMed         Abstract available
    
    
71. WYDERKA R, Drozd J, Ilnicki D, Borger M, et al
    "Scattergun" Right Coronary Artery: Heavy Calcifications in Chronic Total Occlusion Percutaneous Coronary Intervention: A Case Study.
    Catheter Cardiovasc Interv. 2026 Jan 4. doi: 10.1002/ccd.70454.
    PubMed         Abstract available
    
    
72. RIGATELLI G, Marchese G, Hiso E, Bertolini A, et al
    Provisional Versus Nano Inverted T Dual Stenting for Treatment of Complex Left Main Coronary Bifurcation.
    Catheter Cardiovasc Interv. 2026;107:1137-1145.
    PubMed         Abstract available
    
    
73. HAN F, Ma D, Wan Q, Huang Y, et al
    Bailout Retrieval of an Entrapped, Fractured, and Undeflatable Stent Balloon in the Left Main Coronary Artery: A Salvage Procedure During Cardiac Arrest.
    Catheter Cardiovasc Interv. 2026;107:1120-1126.
    PubMed         Abstract available
    
    
74. LIN Z, Zheng Z, Yang M, Liu Q, et al
    Risk Profile and Prognostic Implications of Percutaneous Coronary Intervention Procedure Failure in Patients With Moderate-to-Severe Coronary Artery Calcification.
    Catheter Cardiovasc Interv. 2025 Dec 29. doi: 10.1002/ccd.70452.
    PubMed         Abstract available
    
    
75. ALEJANDRO GB, Sebastian MV, Morales I, Dolores CP, et al
    Seven-Year Clinical Outcomes of a Magnesium Bioresorbable Scaffold in Acute Coronary Syndrome: A Door Opened for the Next Generation.
    Catheter Cardiovasc Interv. 2026;107:1072-1079.
    PubMed         Abstract available
    
    
76. DURMAZ E, Raimoglu D, Incesu G, Raimoglu U, et al
    Underlying Mechanisms of Second-Generation Drug Eluting Stent Thrombosis: An Optical Coherence Tomography Study.
    Catheter Cardiovasc Interv. 2026;107:1031-1038.
    PubMed         Abstract available
    
    
77. O'CALLAGHAN D, Durand R, Hanratty CG, Cuisset T, et al
    A Prospective, Multicenter, Open Label Study Investigating the Implementation of a Standardized Algorithm for Coronary CaLcificatiOn With PlaquE Modification Using UltraSound Guidance to Improve Procedural and Clinical Outcomes (CYCLOPES): Design and
    Catheter Cardiovasc Interv. 2025 Dec 17. doi: 10.1002/ccd.70424.
    PubMed         Abstract available
    
    
78. HAROON MM, Ahmad F, Ali R, Haider S, et al
    Transcatheter Left Ventricular Restoration in Ischemic Heart Failure and Dilated Cardiomyopathy.
    Catheter Cardiovasc Interv. 2026;107:898-908.
    PubMed         Abstract available
    
    
79. HAWRANEK M, Dziewierz A, Kaluzna-Oleksy M, Tomaniak M, et al
    Temporal Trends in Coronary Physiology Testing and Intravascular Imaging Adoption in Poland (2014-2025).
    Catheter Cardiovasc Interv. 2025 Dec 15. doi: 10.1002/ccd.70439.
    PubMed         Abstract available
    
    
80. ASHRAF S, Mujtaba A, Akmal R, Shahab MS, et al
    SYNTAX Score as a Predictor of Angiographic Complexity in Stable Angina and Acute Coronary Syndrome Patients.
    Catheter Cardiovasc Interv. 2025 Dec 15. doi: 10.1002/ccd.70420.
    PubMed         Abstract available
    
    
81. HEMETSBERGER R, Maaroufi A, Hamzaraj K, Andreka J, et al
    Bench Testing Analysis of Perforation Management in the Setting of Bifurcation Coronary Intervention.
    Catheter Cardiovasc Interv. 2025 Dec 12. doi: 10.1002/ccd.70406.
    PubMed         Abstract available
    
    
82. AZIZ D, Yildiz M, Quesada O, Henry TD, et al
    COVID-19 STEMI related to microthrombi may lead to coronary microvascular dysfunction.
    Catheter Cardiovasc Interv. 2023;102:641-645.
    PubMed         Abstract available
    
    
83. KUNA C, Wiedenmayer N, Bradaric C, Presch A, et al
    Ten-year outcomes after percutaneous coronary intervention of in-stent restenosis in saphenous vein grafts.
    Catheter Cardiovasc Interv. 2023;102:646-654.
    PubMed         Abstract available
    
    
84. SALINAS P, Garcia-Camarero T, Jimenez-Kockar M, Regueiro A, et al
    Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry.
    Catheter Cardiovasc Interv. 2023;102:608-619.
    PubMed         Abstract available
    
    
85. NOBRE MENEZES M, Silva B, Silva JL, Rodrigues T, et al
    Segmentation of X-ray coronary angiography with an artificial intelligence deep learning model: Impact in operator visual assessment of coronary stenosis severity.
    Catheter Cardiovasc Interv. 2023;102:631-640.
    PubMed         Abstract available
    
    
86. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Incidence, mechanisms, treatment, and outcomes of donor vessel injury during percutaneous coronary interventions for chronic total occlusion.
    Catheter Cardiovasc Interv. 2023;102:585-593.
    PubMed         Abstract available
    
    
87. SHIOMI H, Kozuma K, Morimoto T, Kadota K, et al
    Ten-year clinical outcomes from a randomized trial comparing new-generation everolimus-eluting stent versus first-generation Sirolimus-eluting stent: Results from the RESET extended study.
    Catheter Cardiovasc Interv. 2023;102:594-607.
    PubMed         Abstract available
    
    
88. CARLINO M, Uretsky BF, Azzalini L, Nascimbene A, et al
    STAR procedure becomes SAFER: First-in-man case series of a new antegrade dissection re-entry technique.
    Catheter Cardiovasc Interv. 2023;102:577-584.
    PubMed         Abstract available
    
    

    
    Chest

89. YOUNG RP, Scott RJ
    Preserved Ratio Impaired Spirometry: A Treatable Trait Identified by Spirometry When Elevated Risk of Lung Cancer and Cardiovascular Death Coexist.
    Chest. 2026;169:592-595.
    PubMed        
    
    
90. DODANI K, Aldoma A, Targa A, Sanchez-de-la-Torre M, et al
    OSA is associated with enhanced coronary collateral circulation and reduced myocardial injury during acute coronary syndromes.
    Chest. 2026 Mar 7:S0012-3692(26)00288-6. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    
91. XU J, Kwon Y, Esmaeili N, Sands SA, et al
    Association of High Cardiovascular Disease Risk Obstructive Sleep Apnea with Incident Atrial Fibrillation: the Multi-Ethnic Study of Atherosclerosis.
    Chest. 2026 Mar 5:S0012-3692(26)00269-2. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    

    
    Circ Arrhythm Electrophysiol

92. YOGESWARAN V, Brody JA, Sitlani CM, Wiggins KL, et al
    Right and Left Atrial Dysfunction as Independent Cardiovascular Risk Factors: A UK Biobank Study.
    Circ Arrhythm Electrophysiol. 2026 Feb 26:e014412.
    PubMed         Abstract available
    
    
93. KRISHNAN V, Shah NS
    Arrhythmia-Related Cardiovascular Disease Mortality Among Asian American, Native Hawaiian, and Pacific Islander Groups.
    Circ Arrhythm Electrophysiol. 2026 Feb 25:e014572.
    PubMed        
    
    

    
    Circ Cardiovasc Imaging

94. ARBAB-ZADEH A
    Disentangling Fact From Fiction: Sex-Specific Characteristics of Coronary Artery Disease.
    Circ Cardiovasc Imaging. 2026 Feb 23:e019556.
    PubMed        
    
    

    
    Circ Cardiovasc Interv

95. KOO CYC, Li S, Al-Lamee R, Cohen DJ, et al
    Angiography-Derived Fractional Flow Reserve During Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2026 Mar 7. doi: 10.1161/CIRCINTERVENTIONS.125.016213.
    PubMed         Abstract available
    
    
96. KERN MJ, Seto AH
    Prognosis for Isolated Coronary Artery Ectasia: Hope for the Best, Expect the Worst.
    Circ Cardiovasc Interv. 2026 Mar 4:e016548.
    PubMed        
    
    
97. VAN DEN BROEK WWA, Azzahhafi J, van de Pol QYF, Chan Pin Yin DRPP, et al
    Genotype-Guided P2Y(12)-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.
    Circ Cardiovasc Interv. 2026 Feb 26:e016084.
    PubMed         Abstract available
    
    

    
    Circ J

98. NISHIYAMA K, Nishihira K, Nakai M, Baba K, et al
    Prognostic Value of Serum Lipoprotein(a) Levels in Japanese Patients With ST-Segment Elevation Myocardial Infarction.
    Circ J. 2026 Mar 7. doi: 10.1253/circj.CJ-25-0889.
    PubMed         Abstract available
    
    

    
    Circ Res

99. ZHAO GJ, Shi HT, Tian X, Chen XX, et al
    USP10 Deubiquitinates MTX2 to Suppress cGAS-STING Signaling in MI.
    Circ Res. 2026;138:e326551.
    PubMed         Abstract available
    
    
100. OMOTO ACM, Vechetti I, do Carmo JM, Wang Z, et al
     Leptin Activates Brain-BAT-Heart Crosstalk to Promote Cardiac Protection.
     Circ Res. 2026;138:e326878.
     PubMed         Abstract available
     
     
101. MA Y, Sun N, Fang Y, Wang Y, et al
     Illuminating the Invisible: Translational Molecular Imaging in Cardiovascular Medicine.
     Circ Res. 2026;138:e327199.
     PubMed         Abstract available
     
     

     
     Circulation

102. ZHU X, Li W, Yu J
     Letter by Zhu et al Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
     Circulation. 2026;153:e913.
     PubMed        
     
     
103. CHU L, Ma X, Chen K
     Response by Chu et al to Letter Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
     Circulation. 2026;153:e914-e915.
     PubMed        
     
     
104. HE J, Zhu Y
     Correction to: Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
     Circulation. 2026;153:e909.
     PubMed        
     
     
105. GAUDINO M, Sandner S, An KR, Dimagli A, et al
     Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up.
     Circulation. 2023;148:1305-1315.
     PubMed         Abstract available
     
     
106. ARAIZA-GARAYGORDOBIL D, Garcia-Jimenez Y, Gopar-Nieto R
     Global Rounds Mexico: Improving Cardiovascular Health Through Integration.
     Circulation. 2026;153:696-698.
     PubMed        
     
     
107. JARR KU, Peters A, Leeper NJ
     Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention.
     Circulation. 2026;153:613-615.
     PubMed        
     
     
108. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
     Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association.
     Circulation. 2026 Feb 25. doi: 10.1161/CIR.0000000000001406.
     PubMed         Abstract available
     
     
109. XIE J, Cheng LM, Liu K
     Letter by Xie et al Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
     Circulation. 2026;153:e109-e110.
     PubMed        
     
     
110. HUANG J, Fogacci F
     Letter by Huang and Fogacci Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
     Circulation. 2026;153:e111-e112.
     PubMed        
     
     
111. BERRY JD, Leonard D, Levine BD, DeFina LF, et al
     Response by Berry et al to Letter Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
     Circulation. 2026;153:e113-e114.
     PubMed        
     
     

     
     Clin Cardiol

112. ZHU Y, Zheng L, Bing J, Teng X, et al
     Interaction Between Composite Dietary Antioxidant Index and Alcohol Consumption on Cardiovascular Diseases: NHANES 2005-2018.
     Clin Cardiol. 2026;49:e70274.
     PubMed         Abstract available
     
     
113. DAS V, Tahir RBE, Bibi S, Saqib HW, et al
     Critique on "Epicardial Fat Thickness as a Marker of Coronary Artery Disease in Diabetics: A Single Center Study".
     Clin Cardiol. 2026;49:e70273.
     PubMed        
     
     

     
     Clin Chem

114. DENESSEN EJS, Swinnen B, Lamers SK, Delnoij TSR, et al
     Cardiac Biomarker Kinetics in Patients after Coronary Artery Bypass Grafting with an Uncomplicated Course.
     Clin Chem. 2026 Feb 24:hvag012. doi: 10.1093.
     PubMed         Abstract available
     
     

     
     Eur Heart J

115. 
     Correction to: Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
     Eur Heart J. 2026 Mar 12:ehag167. doi: 10.1093.
     PubMed        
     
     
116. MA M, Zhang Y, Gao L, Wang Z, et al
     Atherosclerotic progression at sites of low shear stress is attenuated by myeloid-PlexinD1 deficiency through suppression of classical macrophage polarization.
     Eur Heart J. 2026;47:1242-1259.
     PubMed         Abstract available
     
     

     
     Heart

117. CHO MS, Kang DY, Lee JB, Oh YS, et al
     Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial.
     Heart. 2025 Sep 9:heartjnl-2025-326646. doi: 10.1136/heartjnl-2025-326646.
     PubMed         Abstract available
     
     
118. RANKINEN J, Hernesniemi J, Tynkkynen JT
     Atrial fibrillation and the risk of sudden cardiac death: incidence, impact and implications.
     Heart. 2025 Jul 15:heartjnl-2025-326003. doi: 10.1136/heartjnl-2025-326003.
     PubMed         Abstract available
     
     

     
     Hypertension

119. KHAVANDEGAR A, Sachdeva R, Krassioukov A
     Outcome-Based Cardiovascular Risk Framework is Required After Spinal Cord Injury.
     Hypertension. 2026 Feb 24. doi: 10.1161/HYPERTENSIONAHA.125.26543.
     PubMed         Abstract available
     
     

     
     Int J Cardiol

120. COSENTINO N, Velato L, Bonomi A, Morocutti C, et al
     Severe obesity and in-hospital outcomes in acute myocardial infarction: Insights into the role of systemic inflammation.
     Int J Cardiol. 2026 Mar 10:134287. doi: 10.1016/j.ijcard.2026.134287.
     PubMed         Abstract available
     
     
121. OZAWA T, Goto K, Hirokane A, Mizuno T, et al
     Prognostic significance of provocative spasm tests in patients with myocardial infarction with and without obstructive coronary arteries.
     Int J Cardiol. 2026;452:134277.
     PubMed         Abstract available
     
     
122. CHENG A, Wu Y, Mou F, Zhou J, et al
     Drug-coated balloon versus drug-eluting stent for treating de novo proximal left anterior descending artery lesions: Insights from the REC-CAGEFREE I trial.
     Int J Cardiol. 2026;451:134267.
     PubMed         Abstract available
     
     
123. GHETTI G, Taglieri N, Guiducci V, Capecchi A, et al
     Bail-out stenting and target-vessel failure after drug-coated balloon percutaneous coronary angioplasty for de novo lesions: The BOSS study.
     Int J Cardiol. 2026;451:134250.
     PubMed         Abstract available
     
     
124. PRATI F, Biccire FG, Mallus MT, Mastroianni F, et al
     Coronary inflammation: Identification, clinical impact and possible therapeutical solutions.
     Int J Cardiol. 2026;450:134229.
     PubMed         Abstract available
     
     
125. CAI ML, Shi WX, Li J, Li T, et al
     Phase III cardiac rehabilitation improves left ventricular ejection fraction in patients with coronary artery disease and mildly reduced ejection fraction after percutaneous coronary intervention.
     Int J Cardiol. 2026;450:134219.
     PubMed         Abstract available
     
     
126. CHIOTIS S, Giannopoulos G, Boulmpou A, Zgouridou A, et al
     Association of common risk factors with major adverse cardiac events and mortality in patients with MINOCA: A systematic review and meta-analysis.
     Int J Cardiol. 2026;450:134225.
     PubMed         Abstract available
     
     
127. WOUDSTRA J, Dimitriu-Leen AC, Crooijmans C, Yosofi B, et al
     Microvascular vasomotor dysfunction is more prevalent in female versus epicardial vasomotor dysfunction in male ANOCA patients.
     Int J Cardiol. 2026;450:134226.
     PubMed         Abstract available
     
     
128. BUJAK K, Rinaldi R, Vidal-Cales P, Montone RA, et al
     Immediate versus staged complete revascularization in acute coronary syndrome: A meta-analysis of randomized controlled trials.
     Int J Cardiol. 2023;393:131397.
     PubMed         Abstract available
     
     
129. EMMERT-FEES KMF, Luhar S, O'Flaherty M, Kypridemos C, et al
     Forecasting the mortality burden of coronary heart disease and stroke in Germany: National trends and regional inequalities.
     Int J Cardiol. 2023 Sep 25:131359. doi: 10.1016/j.ijcard.2023.131359.
     PubMed         Abstract available
     
     
130. FONDERICO C, Pergola V, Faccenda D, Salucci A, et al
     Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients.
     Int J Cardiol. 2023 Sep 23:131391. doi: 10.1016/j.ijcard.2023.131391.
     PubMed         Abstract available
     
     
131. LIU S, Wang P, Liu C, Jin M, et al
     Effect of PCSK9 antibodies on coronary plaque regression and stabilization derived from intravascular imaging in patients with coronary artery disease: A meta-analysis.
     Int J Cardiol. 2023;392:131330.
     PubMed         Abstract available
     
     
132. LI F, Peng J, Lu Y, Zhou M, et al
     Blockade of CXCR4 promotes macrophage autophagy through the PI3K/AKT/mTOR pathway to alleviate coronary heart disease.
     Int J Cardiol. 2023;392:131303.
     PubMed         Abstract available
     
     
133. WEIGHT N, Moledina S, Rashid M, Chew N, et al
     Temporal analysis of non-ST segment elevation-acute coronary syndrome (NSTEACS) outcomes in 'young' patients under the age of fifty: A nationwide cohort study.
     Int J Cardiol. 2023;391:131294.
     PubMed         Abstract available
     
     
134. KASKI JC, Lluch N, Lopez-Sendon JL, Gorog DA, et al
     Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial.
     Int J Cardiol. 2023;391:131291.
     PubMed         Abstract available
     
     
135. KUZEMCZAK M, Lipiecki J, Jeyalan V, Farhat H, et al
     Clinical outcomes of coronary intravascular lithotripsy in patients with stent failure (COIL registry).
     Int J Cardiol. 2023;391:131274.
     PubMed         Abstract available
     
     
136. DE KONING MLY, Al Ali L, Bourgonje AR, Assa S, et al
     Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction.
     Int J Cardiol. 2023;391:131214.
     PubMed         Abstract available
     
     
137. YIN ZY, Fu T, He SM, Fu L, et al
     16alpha-OHE1, a novel oestrogen metabolite, attenuates dysfunction of left ventricle contractility via regulation of autophagy after myocardial ischemia and reperfusion.
     Int J Cardiol. 2023;388:131123.
     PubMed         Abstract available
     
     

     
     J Am Coll Cardiol

138. HOLLE SLD, Kunkel JB, Hassager C, Wiberg S, et al
     Effect of Low-Dose Dobutamine Infusion on N-Terminal Pro-B-Type Natriuretic Peptide in At-Risk Patients With Acute Myocardial Infarction (DOBERMANN-D): A Randomized Clinical Trial.
     J Am Coll Cardiol. 2026 Mar 7:S0735-1097(26)00130.
     PubMed        
     
     
139. KUNKEL JB, Holle SLD, Hassager C, Pecini R, et al
     Effect of Tocilizumab on Pro-B-Type Natriuretic Peptide and Infarct Size in Patients With Acute Myocardial Infarction at Risk of Cardiogenic Shock (DOBERMANN-T).
     J Am Coll Cardiol. 2026 Mar 7:S0735-1097(26)00129.
     PubMed        
     
     
140. GOLD DA, Maisuradze N, Sandesara PB, Vatsa N, et al
     The Comparative Prognostic Value of High Sensitivity Troponin Level and Stress Testing in Patients With Stable Coronary Artery Disease.
     J Am Coll Cardiol. 2026 Mar 11:S0735-1097(26)00297.
     PubMed        
     
     
141. MENA-HURTADO C, Ahmad D, Mori M
     Real-Time Coronary Heart Teams: Moving From Recommendation to Implementation.
     J Am Coll Cardiol. 2026 Feb 16:S0735-1097(26)00143.
     PubMed        
     
     
142. ARUN AS, Shah RM, Lu Y, Dhruva SS, et al
     Health Care Utilization by Atherosclerotic Cardiovascular Disease Status: A JACC Data Report on Trends in the United States, 2019-2024.
     J Am Coll Cardiol. 2026;87:1157-1160.
     PubMed        
     
     
143. ARUN AS, Shah RM, Lu Y, Dhruva SS, et al
     Sleep Duration by Atherosclerotic Cardiovascular Disease Status: A JACC Data Report on Trends in the United States, 2020-2024.
     J Am Coll Cardiol. 2026;87:1153-1156.
     PubMed        
     
     
144. ARUN AS, Shah RM, Lu Y, Dhruva SS, et al
     Exercise by Atherosclerotic Cardiovascular Disease Status: A JACC Data Report on Trends in the United States, 2020-2024.
     J Am Coll Cardiol. 2026;87:1149-1152.
     PubMed        
     
     
145. SHAH RM, Arun AS, Lu Y, Dhruva SS, et al
     Health Care Affordability by Atherosclerotic Cardiovascular Disease Status: A JACC Data Report on Trends in the United States, 2019-2024.
     J Am Coll Cardiol. 2026;87:1145-1148.
     PubMed        
     
     
146. ARUN AS, Shah RM, Lu Y, Dhruva SS, et al
     Health Care Access by Atherosclerotic Cardiovascular Disease Status: A JACC Data Report on Trends in the United States, 2019-2024.
     J Am Coll Cardiol. 2026;87:1141-1144.
     PubMed        
     
     
147. ARUN AS, Kadakia KT, Krumholz HM
     Cardiovascular Spending and Mortality: A JACC Data Report on Trends in the United States, 2000-2022.
     J Am Coll Cardiol. 2026;87:1138-1140.
     PubMed        
     
     
148. DASH S, Zheng Z, Qian Y, Dhruva SS, et al
     Out-of-Pocket Costs and Financial Burden Among Working-Age Adults With Cardiovascular Conditions: A JACC Data Report on Trends in the United States, 2007-2022.
     J Am Coll Cardiol. 2026;87:1135-1137.
     PubMed        
     
     
149. KNUDSEN AD, Kuhl JT, Schultz NA, Villadsen GE, et al
     Coronary Atherosclerosis in Liver Transplant Recipients and Population Controls: A Nationwide Study Using Protocolized CT Angiography.
     J Am Coll Cardiol. 2026 Mar 4:S0735-1097(26)00207.
     PubMed         Abstract available
     
     
150. GARGIULO G, Piccolo R, Park DW, Nam GB, et al
     Anticoagulation Alone or With Antiaggregation in Patients With Coronary Artery Disease: Meta-Analysis of Randomized Trials.
     J Am Coll Cardiol. 2026 Feb 19:S0735-1097(26)00136.
     PubMed        
     
     
151. LIN S, Su X, Ma H, Dou K, et al
     Real-Time Heart Team for Revascularization in Complex Coronary Artery Disease: The EHEART Randomized Trial.
     J Am Coll Cardiol. 2026 Feb 25:S0735-1097(26)00070.
     PubMed         Abstract available
     
     
152. FREUND A, Spaulding C
     Long-Term Lessons From the COACT Trial: Coronary Angiography After Out-of-Hospital Cardiac Arrest Revisited.
     J Am Coll Cardiol. 2026 Feb 25:S0735-1097(26)00224.
     PubMed        
     
     
153. REGAN JA, Laitner MH, Dzau VJ
     Cardiovascular Science, Medicine, and Society: The Brave New World: The ACC Braunwald Lecture 2025.
     J Am Coll Cardiol. 2026 Feb 17:S0735-1097(26)00073.
     PubMed         Abstract available
     
     
154. KRUMHOLZ HM
     From Survival to Stewardship: Delivering Hyperspecialized Cardiovascular Care at Scale.
     J Am Coll Cardiol. 2026;87:753-755.
     PubMed        
     
     

     
     J Cardiovasc Pharmacol

155. TAN J, Gu J
     The Multifaceted Role of Angiopoietin-Like Proteins in Coronary Heart Disease: From Molecular Mechanisms to Clinical Translation.
     J Cardiovasc Pharmacol. 2026 Mar 2. doi: 10.1097/FJC.0000000000001815.
     PubMed         Abstract available
     
     
156. WEBER B, McCarty D, Robar C, Fainberg U, et al
     Patients' and Healthcare Professionals' Perspectives in Managing Atherosclerotic Cardiovascular Disease: A Survey of Unmet Needs and Perceived Benefits of Treating Systemic Inflammation in Cardiovascular Diseases.
     J Cardiovasc Pharmacol. 2026 Feb 25. doi: 10.1097/FJC.0000000000001800.
     PubMed         Abstract available
     
     

     
     J Clin Endocrinol Metab

157. OKUBO J, Kawahara EZ, Mori GH, Calsavara VF, et al
     High Normal Parathyroid Hormone and Cardiovascular and Total Mortality: Sex and Age Disparities in the ELSA-Brasil Study.
     J Clin Endocrinol Metab. 2026 Feb 24:dgag076. doi: 10.1210.
     PubMed         Abstract available
     
     

     
     J Electrocardiol

158. KARAMAN K
     Letter to the editor: "The value of P wave parameters in predicting proximal or distal right coronary artery occlusion in patients with inferior myocardial infarction": In response to: Efe SC, Karacam M, Tekatli AF, et al. The value of P wave paramete
     J Electrocardiol. 2026;97:154225.
     PubMed        
     
     
159. TOMCSANYI J, Papp E, Bozsik B
     Distinctive electrocardiographic pattern in acute myocardial infarction.
     J Electrocardiol. 2026;95:154217.
     PubMed         Abstract available
     
     
160. ZHANG AJ, Chelu MG, Taing K, Birnbaum Y, et al
     P-wave peak time: An emerging electrocardiographic marker of atrial stress and ischemic burden-review.
     J Electrocardiol. 2026;95:154211.
     PubMed         Abstract available
     
     
161. LI YY, Zeng F, Deng J, Huang B, et al
     The value of ST-segment deviation in lead aVR for predicting the infarct-related artery in acute inferior STEMI: A systematic review and meta-analysis.
     J Electrocardiol. 2026;95:154196.
     PubMed         Abstract available
     
     
162. WANG Z, Wang S, Liu M, Li D, et al
     Exercise high-frequency QRS versus exercise stress electrocardiography in diagnosing myocardial ischemia: A meta-analysis.
     J Electrocardiol. 2026;95:154190.
     PubMed         Abstract available
     
     
163. GRANATA LG, Busa A, Marchetta M, Alagna G, et al
     Beyond STEMI criteria: The electrocardiographic "South African Flag Sign" revealing an isolated proximal ramus intermedius occlusion.
     J Electrocardiol. 2026;95:154195.
     PubMed         Abstract available
     
     

     
     J Mol Cell Cardiol

164. MOSCARELLI M, Skeffington KL, Fudulu D, Punjabi P, et al
     Left and right myocardial ventricular energetics during cardioplegic ischemic arrest and reperfusion in patients undergoing cardiac surgery.
     J Mol Cell Cardiol. 2026;213:84-92.
     PubMed         Abstract available
     
     
165. DE OLIVEIRA DF, Maciel L, Dos Santos Silva A, Da Coutinho KC, et al
     The C-domain of the cerebral dopamine neurotrophic factor (CDNF) is responsible for its cardioprotective activity by binding to the KDEL receptor relocated to the plasma membrane under endoplasmic reticulum stress conditions.
     J Mol Cell Cardiol. 2026;213:32-47.
     PubMed         Abstract available
     
     
166. XIAO Z, Wei X, Li M, Yang K, et al
     Myeloid-specific deletion of Capns1 attenuates myocardial infarction injury via restoring mitochondrial function and inhibiting inflammasome activation.
     J Mol Cell Cardiol. 2023;183:54-66.
     PubMed         Abstract available
     
     

     
     J Nucl Med

167. HARTRAMPF PE, Werner RA, Higuchi T, Schottelius M, et al
     Is CXCR4 Theranostics in Oncologic, Cardiovascular, and Inflammatory Diseases Really Happening?
     J Nucl Med. 2026 Mar 12:jnumed.125.271153. doi: 10.2967/jnumed.125.271153.
     PubMed        
     
     
168. ALWAN M, Sayed A, El Yaman A, Shaikh A, et al
     Prevalence, Predictors, and Outcomes of Impaired Myocardial Flow Reserve Among Symptomatic Patients with a Coronary Artery Calcium Score of 0.
     J Nucl Med. 2026 Feb 26:jnumed.125.271141. doi: 10.2967/jnumed.125.271141.
     PubMed         Abstract available
     
     

     
     J Thorac Cardiovasc Surg

169. YALAMANCHILI K, Stone C, Muir KC, Harris DD, et al
     Metformin's Effects Beyond Ischemia: Evaluating Cardioprotection in Non-Ischemic Myocardium in a Large Animal Model of Coronary and Metabolic Disease.
     J Thorac Cardiovasc Surg. 2025 Oct 13:S0022-5223(25)00868.
     PubMed         Abstract available
     
     
170. AHMAD A, Williams AM, Trahanas J, Bommareddi S, et al
     Oxygen Extraction Trajectories During Cardiopulmonary Bypass Impact Postoperative Outcomes in Coronary Artery Bypass Grafting.
     J Thorac Cardiovasc Surg. 2026 Feb 26:S0022-5223(26)00175.
     PubMed         Abstract available
     
     

     
     J Thromb Haemost

171. HELTEN C, Benkhoff M, Mourikis P, Metzen D, et al
     Acetylsalicylic acid improves outcome after acute myocardial infarction by reduction of thromboinflammation.
     J Thromb Haemost. 2026 Mar 4:S1538-7836(26)00119.
     PubMed         Abstract available
     
     

     
     JAMA

172. ABBASI J
     MASALA Study Suggests Earlier Cardiovascular Vigilance Needed for People With South Asian Ancestry.
     JAMA. 2026 Mar 13. doi: 10.1001/jama.2026.1798.
     PubMed        
     
     
173. EINSTEIN AJ, Williams MC, Weir-McCall JR, Shaw LJ, et al
     Worldwide Radiation Dose in Coronary Artery Disease Diagnostic Imaging.
     JAMA. 2026 Feb 25:e260703. doi: 10.1001/jama.2026.0703.
     PubMed         Abstract available
     
     
174. ANDERER S
     Cardiovascular Disease Risk Climbs Earlier for Men.
     JAMA. 2026 Feb 20. doi: 10.1001/jama.2025.26395.
     PubMed        
     
     

     
     Lancet

175. VALGIMIGLI M, Gragnano F, Giacoppo D
     Clopidogrel versus aspirin for coronary artery disease - Authors' reply.
     Lancet. 2026;407:853-854.
     PubMed        
     
     
176. IBRAHIM A, Shalabi L, Ando G
     Clopidogrel versus aspirin for coronary artery disease.
     Lancet. 2026;407:853.
     PubMed        
     
     
177. DELLO RUSSO C, Venetucci L, Ramlogan R, Gagliardi D, et al
     Clopidogrel versus aspirin for coronary artery disease.
     Lancet. 2026;407:852-853.
     PubMed        
     
     
178. COLLI A, Casazza G, Gluud C
     Clopidogrel versus aspirin for coronary artery disease.
     Lancet. 2026;407:851-852.
     PubMed        
     
     

     
     Mayo Clin Proc

179. LIPPI G, Mattiuzzi C, Lavie CJ
     Epidemiology of Mortality for Acute Myocardial Infarction in the United States: 2024 Update.
     Mayo Clin Proc. 2026 Mar 5:S0025-6196(26)04330.
     PubMed        
     
     
180. NAGARAJA V, Lewis BR, Korsapati H, Mene-Afejuku TO, et al
     Ten-Year Clinical Outcomes and Cause of Death in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: A Retrospective Mayo Clinic PCI Registry Analysis.
     Mayo Clin Proc. 2026 Mar 5:S0025-6196(25)16631.
     PubMed         Abstract available
     
     
181. SOMERS KR, Bock JM, Covassin N, Bukartyk J, et al
     Acute Cardiovascular Responses to Amphetamine/Dextroamphetamine Salts (Adderall) in Adderall-Naive Young Adults: A Randomized Clinical Trial.
     Mayo Clin Proc. 2026 Mar 2:S0025-6196(25)18157.
     PubMed         Abstract available
     
     

     
     N Engl J Med

182. LUSCHER TF, Wenzl FA
     Beta-Blockers after Myocardial Infarction - Toward Personalized Management.
     N Engl J Med. 2026;394:599-602.
     PubMed        
     
     
183. GUIMARAES PO, Franken M, Lemos PA
     Aspirin after PCI in Acute Coronary Syndromes. Reply.
     N Engl J Med. 2026;394:1036-1037.
     PubMed        
     
     
184. CHAN SCH
     Aspirin after PCI in Acute Coronary Syndromes.
     N Engl J Med. 2026;394:1036.
     PubMed        
     
     
185. LI M, Zhang G, Liu X
     Aspirin after PCI in Acute Coronary Syndromes.
     N Engl J Med. 2026;394:1035-1036.
     PubMed        
     
     
186. STRASSMEIR ML, Baumer U, Niessner A
     Aspirin after PCI in Acute Coronary Syndromes.
     N Engl J Med. 2026;394:1035.
     PubMed        
     
     
187. FEARON WF
     Assessing Nonculprit Coronary-Artery Lesions in STEMI.
     N Engl J Med. 2026;394:1021-1022.
     PubMed        
     
     

     
     PLoS One

188. WANG Y, Li H, Mou W, Zhu J, et al
     Proteomics-based biomarkers of plasma exosomes from patients with acute myocardial infarction.
     PLoS One. 2026;21:e0343804.
     PubMed         Abstract available
     
     
189. ZUAZAGOITIA-LAMA-NORIEGA JM, Gomez-Gonzalez AM, Moral-Munoz JA
     Effectiveness of adding inspiratory muscle training to a cardiac rehabilitation program in people with acute myocardial infarction revascularized by percutaneous coronary intervention (CARDIOINSPIRE): Study protocol for a randomized controlled trial.
     PLoS One. 2026;21:e0343947.
     PubMed         Abstract available
     
     
190. AMIER RP, Beijnink CWH, Rodriguez Palomares JF, Smulders MW, et al
     Long-term prognostic value of microvascular obstruction by cardiac magnetic resonance in ST-segment elevation myocardial infarction.
     PLoS One. 2026;21:e0344442.
     PubMed         Abstract available
     
     
191. LATIR A, Hafiz E, Suhaimi A
     Concurrent training in cardiac rehabilitation: A scoping review of aerobic-strength combinations in patients with coronary artery disease.
     PLoS One. 2026;21:e0344208.
     PubMed         Abstract available
     
     
192. HUMMEL B, van Schalkwijk DL, Zipfel N, Tuithof PTC, et al
     Implementation and product- and process evaluation of a co-created gender-informed and culturally-sensitive toolkit to improve symptom recognition and care seeking for ischemic heart disease: RE-AIM framework.
     PLoS One. 2026;21:e0344093.
     PubMed         Abstract available
     
     

     
     Prog Cardiovasc Dis

193. KANG J, Kim HJ, Yim Y, Kim MS, et al
     Wearable-derived REM sleep as a modifiable risk factor for cardiovascular disease: A multimodal prediction model in the All of Us Research Program.
     Prog Cardiovasc Dis. 2026 Mar 4:S0033-0620(26)00014.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum